CRF Bracket announced the launch of a new Planning module added within SmartSupplies. Offering simplicity, visualization and control to life science companies, this module makes SmartSupplies the only fully integrated, 21 CRF Part 11compliant solution that enables closed-loop conduct of clinical supply forecasting, planning and inventory management.
The SmartSupplies Planning module will modernize how life science companies generate clinical supply manufacturing plans, replacing cumbersome, tedious spreadsheets. It dynamically graphs clinical supply and demand at the project and program levels using real-time forecast data pulled in directly from the SmartSupplies Forecasting module or from any other external sources such as simulation tools and spreadsheets.
Using the Smart Supplies Planning, Forecasting, and Inventory Management as a completely integrated solution produces a comprehensive end-to-end solution that digitally controls, tracks and traces the entire clinical supply chain. The Planning Module can also be used as a standalone solution to collate and visualize disparate sources of imported demand to enable aggregated supply and asset planning.
“Clinical supply chains can be complex to manage due to variability that results from protocol changes, undefined doses, unexpected recruitment rates, batch failures and non-availability of raw materials, among other challenges,” says Oliver Cunningham, Senior Director of Client Enablement, SmartSupplies, CRF Bracket.“SmartSupplies changes that-it’s purpose-built to fully digitize the entire clinical supply chain. By integratingforecasting, planning and inventory managementthe system enables on-demand lot recall and offers full traceability.”
The SmartSupplies Forecasting & Planning solutions will help sponsors reduce the effort required to build forecasts, make better manufacturing decisions, and reduce supply overages and associated costs. Companies like AstraZenecahave already made the enterprise-wide switch from Excel to SmartSupplies, saving 10% of their clinical supply budget, representing millions of US dollars annually, through better forecasting. The addition of the SmartSupplies Planning model will further increase the visibility of all supply chain activities and allow the system to optimize manufacturing plans thereby lowing the risk of stockouts or overproduction of investigational medicinal product.
To learn more about SmartSupplies Forecasting & Planning and SmartSupplies Inventory Management, visit http://pages.crfhealth.com/SmartSupplies_Forecasting_Planning.html
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.